1. Center of Cellular Therapy G. Lanzani, Division of Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy;
2. Department of Biomedical Engineering, Istituto di Ricerche Farmacologiche Mario Negri, Istituto di Ricovero e Cura a Carattere Scientifico, Bergamo, Italy; and
3. Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland